Mandated? Voluntary: Firm initiated. Recall Number, D- . Event ID, . Brand, CATHFLO ACTIVASE. Generic Name, ALTEPLASE. Manufacturer, ALTEPLASE.
August 15: Alteplase Injection (Cathflo Activase) Shortage. Products affected. Cathflo Activase intravenous lyophilized powder for injection
The purpose of this letter is to inform you about the potential risk of impact on the sterility of Cathflo Activase (alteplase) and the voluntary recall of two batches of Cathflo Activase (alteplase) (batches ).
Cathflo Activase is a drug product recalled by Genentech due to deformed stoppers observed during filling operations. The recall is ongoing and the latest recall number is D- for lot numbers .
Alteplase Injection (Cathflo Activase),, . Ambrisentan Galcanezumab-gnlm (Emgality),, . Gentamicin
Ma . Important Drug Information Cathflo Activase (alteplase): NDC Dear Pharmacist: Subject: Cathflo Activase (alteplase) should be filtered with a 5 micron
Alteplase Injection (Cathflo Activase),, . Ambrisentan Dicyclomine Oral Presentations,, . Difluprednate
Cathflo Activase Description. Cathflo Activase (Alteplase) is a tissue plasminogen activator (t‑PA) produced by recombinant DNA technology. It is a sterile, purified glycoprotein of 527 amino acids.
Alteplase Injection (Cathflo Activase),, . Ambrisentan Galcanezumab-gnlm (Emgality),, . Gentamicin
Comments